Data as of Apr 15
| -0.03 / -1.32%|
The 4 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 9.50, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a +320.35% increase from the last price of 2.26.
The current consensus among 4 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.